111 related articles for article (PubMed ID: 36244180)
1. [Risk factors for COVID-19 severe complications comparing three major epidemiological waves: An approach from primary health care in Mexico].
Oliva-Sánchez PF; Vadillo-Ortega F; Bojalil-Parra R; Martínez-Kobeh JP; Pérez-Pérez JR; Pérez-Avalos JL
Aten Primaria; 2022 Nov; 54(11):102469. PubMed ID: 36244180
[TBL] [Abstract][Full Text] [Related]
2. Comparative epidemiology of five waves of COVID-19 in Mexico, March 2020-August 2022.
Ascencio-Montiel IJ; Ovalle-Luna OD; Rascón-Pacheco RA; Borja-Aburto VH; Chowell G
BMC Infect Dis; 2022 Oct; 22(1):813. PubMed ID: 36316634
[TBL] [Abstract][Full Text] [Related]
3. Determinants of survival after severe acute respiratory syndrome coronavirus 2 infection in Mexican outpatients and hospitalised patients.
Prado-Galbarro FJ; Sanchez-Piedra C; Gamiño-Arroyo AE; Cruz-Cruz C
Public Health; 2020 Dec; 189():66-72. PubMed ID: 33166857
[TBL] [Abstract][Full Text] [Related]
4. Increased Risk of Hospitalization and Death in Patients with COVID-19 and Pre-existing Noncommunicable Diseases and Modifiable Risk Factors in Mexico.
Hernández-Galdamez DR; González-Block MÁ; Romo-Dueñas DK; Lima-Morales R; Hernández-Vicente IA; Lumbreras-Guzmán M; Méndez-Hernández P
Arch Med Res; 2020 Oct; 51(7):683-689. PubMed ID: 32747155
[TBL] [Abstract][Full Text] [Related]
5. Unequal Impact of Structural Health Determinants and Comorbidity on COVID-19 Severity and Lethality in Older Mexican Adults: Considerations Beyond Chronological Aging.
Bello-Chavolla OY; González-Díaz A; Antonio-Villa NE; Fermín-Martínez CA; Márquez-Salinas A; Vargas-Vázquez A; Bahena-López JP; García-Peña C; Aguilar-Salinas CA; Gutiérrez-Robledo LM
J Gerontol A Biol Sci Med Sci; 2021 Feb; 76(3):e52-e59. PubMed ID: 32598450
[TBL] [Abstract][Full Text] [Related]
6. Obesity is a strong risk factor for short-term mortality and adverse outcomes in Mexican patients with COVID-19: a national observational study.
Vera-Zertuche JM; Mancilla-Galindo J; Tlalpa-Prisco M; Aguilar-Alonso P; Aguirre-García MM; Segura-Badilla O; Lazcano-Hernández M; Rocha-González HI; Navarro-Cruz AR; Kammar-García A; Vidal-Mayo JJ
Epidemiol Infect; 2021 Apr; 149():e109. PubMed ID: 33913410
[TBL] [Abstract][Full Text] [Related]
7. IMPACT OF COMORBIDITIES IN MEXICAN SARS-COV-2-POSITIVE PATIENTS: A RETROSPECTIVE ANALYSIS IN A NATIONAL COHORT.
Kammar-García A; Vidal-Mayo JJ; Vera-Zertuche JM; Lazcano-Hernández M; Vera-López O; Segura-Badilla O; Aguilar-Alonso P; Navarro-Cruz AR
Rev Invest Clin; 2020; 72(3):151-158. PubMed ID: 32584330
[TBL] [Abstract][Full Text] [Related]
8. Predicting Mortality Due to SARS-CoV-2: A Mechanistic Score Relating Obesity and Diabetes to COVID-19 Outcomes in Mexico.
Bello-Chavolla OY; Bahena-López JP; Antonio-Villa NE; Vargas-Vázquez A; González-Díaz A; Márquez-Salinas A; Fermín-Martínez CA; Naveja JJ; Aguilar-Salinas CA
J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32474598
[TBL] [Abstract][Full Text] [Related]
9. Chronic comorbidities and clinical outcomes in patients with and without COVID-19: a large population-based study using national administrative healthcare open data of Mexico.
Martos-Benítez FD; Soler-Morejón CD; García-Del Barco D
Intern Emerg Med; 2021 Sep; 16(6):1507-1517. PubMed ID: 33411264
[TBL] [Abstract][Full Text] [Related]
10. [Epidemiological and clinical characteristics of the COVID-19 epidemic in Mexico: Quintana Roo case].
Jiménez-Báez MV; Sandoval-Jurado L; Santiago-Espinosa O; Ramírez-Aranda JM; Romero-Figueroa MDS; Montiel-Jarquín A; Prieto-Torres ME
Rev Med Inst Mex Seguro Soc; 2022 Oct; 60(6):657-665. PubMed ID: 36283034
[TBL] [Abstract][Full Text] [Related]
11. Pregnant women with SARS-CoV-2 infection are at higher risk of death and pneumonia: propensity score matched analysis of a nationwide prospective cohort (COV19Mx).
Martinez-Portilla RJ; Sotiriadis A; Chatzakis C; Torres-Torres J; Espino Y Sosa S; Sandoval-Mandujano K; Castro-Bernabe DA; Medina-Jimenez V; Monarrez-Martin JC; Figueras F; Poon LC
Ultrasound Obstet Gynecol; 2021 Feb; 57(2):224-231. PubMed ID: 33320401
[TBL] [Abstract][Full Text] [Related]
12. The Association of Obesity, Type 2 Diabetes, and Hypertension with Severe Coronavirus Disease 2019 on Admission Among Mexican Patients.
Denova-Gutiérrez E; Lopez-Gatell H; Alomia-Zegarra JL; López-Ridaura R; Zaragoza-Jimenez CA; Dyer-Leal DD; Cortés-Alcala R; Villa-Reyes T; Gutiérrez-Vargas R; Rodríguez-González K; Escondrillas-Maya C; Barrientos-Gutiérrez T; Rivera JA; Barquera S
Obesity (Silver Spring); 2020 Oct; 28(10):1826-1832. PubMed ID: 32610364
[TBL] [Abstract][Full Text] [Related]
13. Early estimation of the risk factors for hospitalization and mortality by COVID-19 in Mexico.
Carrillo-Vega MF; Salinas-Escudero G; García-Peña C; Gutiérrez-Robledo LM; Parra-Rodríguez L
PLoS One; 2020; 15(9):e0238905. PubMed ID: 32915872
[TBL] [Abstract][Full Text] [Related]
14. Clinical and Epidemiological Features of SARS-CoV-2 Patients in SARI Ward of a Tertiary Care Centre in New Delhi.
Aggarwal A; Shrivastava A; Kumar A; Ali A
J Assoc Physicians India; 2020 Jul; 68(7):19-26. PubMed ID: 32602676
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 infection fatality rate after the first epidemic wave in Mexico.
Torres-Ibarra L; Basto-Abreu A; Carnalla M; Torres-Alvarez R; Reyes-Sanchez F; Hernández-Ávila JE; Palacio-Mejia LS; Alpuche-Aranda C; Shamah-Levy T; Rivera JA; Barrientos-Gutierrez T
Int J Epidemiol; 2022 May; 51(2):429-439. PubMed ID: 35157072
[TBL] [Abstract][Full Text] [Related]
16. Genomic Characterization of SARS-CoV-2 Isolated from Patients with Distinct Disease Outcomes in Mexico.
Boukadida C; Taboada B; Escalera-Zamudio M; Isa P; Ramírez-González JE; Vazquez-Perez JA; Muñoz-Medina JE; Grajales-Muñiz C; González-Torres C; Gaytán-Cervantes FJ; Rincón-Rubio A; Matías-Florentino M; Esteban Paz-Juárez H; Sanchez-Flores A; Mendieta-Condado E; Barrera-Badillo G; Hernández-Rivas L; López S; López-Martínez I; Ávila-Ríos S; Arias CF
Microbiol Spectr; 2022 Feb; 10(1):e0124921. PubMed ID: 35019701
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics and outcomes in a cohort of oncologic patients with COVID-19 during the first year of the pandemic in Mexico.
De-la-Rosa-Martinez D; Aranda-Audelo M; Martin-Onraet A; Islas-Muñoz B; Perez-Jimenez C; Alatorre-Fernandez P; Cornejo-Juarez P; Ruiz-Garcia E; Zinser-Peniche P; Nuñez-Luna L; Meneses-Garcia A; Herrera-Gomez A; Vilar-Compte D
Cancer Med; 2022 Apr; 11(8):1827-1836. PubMed ID: 35166033
[TBL] [Abstract][Full Text] [Related]
18. Comorbidities associated with maternal mortality from COVID-19 in Mexico.
López-Rodríguez G; Galván M; Valencia ÓG
Gac Med Mex; 2021; 157(6):599-603. PubMed ID: 35108243
[TBL] [Abstract][Full Text] [Related]
19. Risk factors associated with SARS-CoV-2 pneumonia in the pediatric population.
Moreno-Noguez M; Rivas-Ruiz R; Roy-García IA; Pacheco-Rosas DO; Moreno-Espinosa S; Flores-Pulido AA
Bol Med Hosp Infant Mex; 2021; 78(4):251-258. PubMed ID: 34351892
[TBL] [Abstract][Full Text] [Related]
20. Increased levels of soluble fms-like tyrosine kinase-1 are associated with adverse outcome in pregnant women with COVID-19.
Torres-Torres J; Espino-Y-Sosa S; Poon LC; Solis-Paredes JM; Estrada-Gutierrez G; Espejel-Nuñez A; Juarez-Reyes A; Etchegaray-Solana A; Alfonso-Guillen Y; Aguilar-Andrade L; Hernández-Pacheco JA; Villafan-Bernal JR; Martinez-Portilla RJ
Ultrasound Obstet Gynecol; 2022 Feb; 59(2):202-208. PubMed ID: 34664753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
